Harmonizing Global Biospecimen Consent Practices to Advance Translational Research – A Call to Action

New article on the American Society for Clinical Pharmacology & Therapeutics provides a cross-industry review of the complexity of informed consent for translational research conducted across jurisdictions in global research programs. Amelia Warner, CEO of Global Specimen Solutions, Inc. is a contributing Author.

Click Here to Read the Full Article